FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach

Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts

(2011) Bing Tang et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Unknown

(2011) Gerd Gauglitz et al.   MOLECULAR MEDICINE

Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid

(2010) Yi-Chiang Hsu et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Mechanisms of transforming growth factor β1/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts

(2009) S. He et al.   BRITISH JOURNAL OF DERMATOLOGY

Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management

(2009) Dolores Wolfram et al.   DERMATOLOGIC SURGERY

Troglitazone suppresses transforming growth factor-β1-induced collagen type I expression in keloid fibroblasts

(2008) G-Y. Zhang et al.   BRITISH JOURNAL OF DERMATOLOGY